Atlas Trials

A Safety and Tolerability Study of AG-519 in Healthy Subjects

Clinical trial NCT02630927 · TERMINATED

Trial details

NCT number
NCT02630927
Sponsor
Agios Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Anemia
Start date
2015-12-01
Primary completion
2016-12-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.